Pure Global

Tobacco Exposure and Influencing Factors of Smoking Cessation Among Chronic Kidney Disease Patients - Trial NCT06303089

Access comprehensive clinical trial information for NCT06303089 through Pure Global AI's free database. This phase not specified trial is sponsored by Sun Yat-sen University and is currently Not yet recruiting. The study focuses on Smoking Cessation. Target enrollment is 554 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06303089
Not yet recruiting
other
Trial Details
ClinicalTrials.gov • NCT06303089
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Tobacco Exposure and Influencing Factors of Smoking Cessation Among Chronic Kidney Disease Patients
Tobacco Exposure and Influencing Factors of Smoking Cessation Among Chronic Kidney Disease Patients: A Cross-Sectional Study.

Study Focus

Smoking Cessation

Questionnaires set

Observational

other

Sponsor & Location

Sun Yat-sen University

Guangzhou, China

Timeline & Enrollment

N/A

Apr 01, 2024

Mar 01, 2025

554 participants

Primary Outcome

Prevalence of current smokers,Abstinence rates

Summary

The purpose of this study is to describe the tobacco exposure and characteristics of patients
 with Chronic Kidney Disease (CKD) who quit smoking, to identify patients' tobacco-related
 knowledge, attitude, and practice (KAP) and explore the influencing factors of smoking
 cessation.

ICD-10 Classifications

Mental and behavioural disorders due to use of tobacco withdrawal state
Tobacco use
Exposure to tobacco smoke
Toxic effect: Tobacco and nicotine
Mental and behavioural disorders due to use of tobacco

Data Source

ClinicalTrials.gov

NCT06303089

Non-Device Trial